ALUMINUM CHLORIDE

ALUMINUM CHLORIDE was reported 151 times

ALUMINUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 POPLITEAL ARTERY ENTRAPMENT SYNDROME 1 0.2000
1 LIP COSMETIC PROCEDURE 1 0.1250
2 PHOTOREFRACTIVE KERATECTOMY 1 0.0714
3 AQUAGENIC WRINKLING OF PALMS 1 0.0500
4 ALCOHOL TEST POSITIVE 1 0.0213
5 EYE ABRASION 1 0.0189
6 AUTOPHONY 1 0.0133
7 VERTEBROBASILAR ARTERY DISSECTION 1 0.0114
8 LIPOMA EXCISION 1 0.0093
9 CATHETER SITE DISCOLOURATION 1 0.0082
10 DEVICE DEPENDENCE 1 0.0064
11 DEAFNESS PERMANENT 1 0.0051
12 DEVICE COMPUTER ISSUE 1 0.0033
13 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
14 DEPENDENCE ON RESPIRATOR 1 0.0025
15 BLOOD URIC ACID ABNORMAL 1 0.0025
16 TONGUE ERUPTION 1 0.0020
17 PATELLOFEMORAL PAIN SYNDROME 1 0.0019
18 INTERTRIGO 1 0.0018
19 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
20 PALATAL DISORDER 1 0.0017
21 ALLERGY TO METALS 1 0.0016
22 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
23 SOCIAL ANXIETY DISORDER 1 0.0015
24 MAST CELL ACTIVATION SYNDROME 2 0.0014
25 TRAUMATIC FRACTURE 1 0.0014
26 SMALL FIBRE NEUROPATHY 1 0.0014
27 TRACHEITIS 1 0.0013
28 COLONIC ABSCESS 1 0.0012
29 DEVICE LOOSENING 1 0.0012
30 ENDOCRINE OPHTHALMOPATHY 1 0.0012
31 SKIN TEXTURE ABNORMAL 1 0.0010
32 EYELID RASH 1 0.0010
33 SKIN OEDEMA 1 0.0010
34 PRODUCT NAME CONFUSION 1 0.0009
35 PERIRECTAL ABSCESS 1 0.0009
36 CATHETER SITE DISCHARGE 1 0.0009
37 LUMBAR RADICULOPATHY 1 0.0009
38 PULMONARY INFARCTION 2 0.0008
39 BILE DUCT STENOSIS 1 0.0008
40 CHRONIC RESPIRATORY FAILURE 1 0.0008
41 XEROSIS 1 0.0008
42 BLADDER DISCOMFORT 1 0.0008
43 OVARIAN CYST RUPTURED 1 0.0008
44 INFUSION SITE RASH 1 0.0007
45 MYELITIS TRANSVERSE 1 0.0007
46 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
47 GENERALISED ANXIETY DISORDER 1 0.0007
48 PALLIATIVE CARE 1 0.0007
49 TRANSCRIPTION MEDICATION ERROR 1 0.0006
50 AORTIC VALVE DISEASE 1 0.0006
51 TONGUE COATED 1 0.0006
52 VERTIGO POSITIONAL 1 0.0006
53 INFUSION SITE DISCHARGE 1 0.0006
54 APPLICATION SITE DISCOMFORT 1 0.0006
55 PNEUMOMEDIASTINUM 1 0.0006
56 DIFFUSE ALOPECIA 1 0.0005
57 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
58 REBOUND ATOPIC DERMATITIS 1 0.0005
59 CHEST INJURY 1 0.0005
60 PRE-EXISTING CONDITION IMPROVED 3 0.0005
61 PERIARTHRITIS 1 0.0004
62 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
63 PANNICULITIS 1 0.0004
64 APPLICATION SITE BURN 2 0.0004
65 ABNORMAL UTERINE BLEEDING 1 0.0004
66 SKIN DISCOMFORT 1 0.0004
67 SKIN WRINKLING 1 0.0004
68 CLUMSINESS 1 0.0004
69 NECK INJURY 1 0.0003
70 CENTRAL VENOUS CATHETERISATION 1 0.0003
71 INFUSION SITE PRURITUS 1 0.0003
72 FACET JOINT SYNDROME 1 0.0003
73 SKIN INJURY 1 0.0003
74 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
75 LOGORRHOEA 1 0.0003
76 FACIAL PARESIS 1 0.0003
77 MAJOR DEPRESSION 2 0.0003
78 DERMATITIS CONTACT 3 0.0003
79 PARANASAL SINUS HYPERSECRETION 1 0.0003
80 OESOPHAGEAL ULCER 1 0.0003
81 SOCIAL PROBLEM 1 0.0002
82 SUICIDAL BEHAVIOUR 1 0.0002
83 SELF-INJURIOUS IDEATION 1 0.0002
84 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
85 INTERVERTEBRAL DISC DISORDER 1 0.0002
86 ALCOHOLISM 1 0.0002
87 CHAPPED LIPS 1 0.0002
88 ONYCHOMYCOSIS 1 0.0002
89 RHINITIS ALLERGIC 1 0.0002
90 IRON DEFICIENCY 1 0.0002
91 EYE OPERATION 1 0.0002
92 SYNOVIAL CYST 1 0.0002
93 ENTEROCOCCAL INFECTION 1 0.0002
94 HORMONE LEVEL ABNORMAL 1 0.0002
95 DYSLIPIDAEMIA 1 0.0002
96 INJECTION SITE DISCHARGE 1 0.0002
97 CHEILITIS 1 0.0002
98 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
99 SKIN INFECTION 2 0.0002
100 URINE ODOUR ABNORMAL 1 0.0002
101 DECREASED INTEREST 1 0.0002
102 PIGMENTATION DISORDER 1 0.0002
103 NASAL DRYNESS 1 0.0002
104 EYE MOVEMENT DISORDER 1 0.0001
105 DROOLING 1 0.0001
106 THERMAL BURN 1 0.0001
107 SENSITIVE SKIN 1 0.0001
108 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
109 FEELING DRUNK 1 0.0001
110 DERMATITIS ATOPIC 7 0.0001
111 APNOEA 1 0.0001
112 RENAL CYST 1 0.0001
113 POST PROCEDURAL INFECTION 1 0.0001
114 SHOCK HAEMORRHAGIC 1 0.0001
115 DECUBITUS ULCER 1 0.0001
116 POLYURIA 1 0.0001
117 SPINAL COMPRESSION FRACTURE 1 0.0001
118 INFUSION SITE ERYTHEMA 1 0.0001
119 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
120 FACIAL PARALYSIS 1 0.0001
121 SKIN HYPERPIGMENTATION 1 0.0001
122 IMMUNOSUPPRESSION 1 0.0001
123 FLANK PAIN 1 0.0001
124 ARTERIOSCLEROSIS 1 0.0001
125 SPINAL DISORDER 1 0.0001
126 INTENTIONAL DOSE OMISSION 3 0.0001
127 INCREASED APPETITE 2 0.0001
128 COELIAC DISEASE 1 0.0001
129 PERITONITIS BACTERIAL 1 0.0001
130 DISCOMFORT 6 0.0001
131 INITIAL INSOMNIA 1 0.0001
132 PRODUCT ODOUR ABNORMAL 1 0.0001
133 JOINT DISLOCATION 1 0.0001
134 RENAL PAIN 1 0.0001
135 HYPOTHYROIDISM 3 0.0001
136 POOR QUALITY SLEEP 2 0.0001
137 SKIN LACERATION 1 0.0001
138 PULMONARY THROMBOSIS 1 0.0001
139 OESOPHAGITIS 1 0.0001
140 THERAPY NON-RESPONDER 4 0.0001
141 BACTERAEMIA 1 0.0001
142 WRIST FRACTURE 1 0.0001
143 THYROID CANCER 1 0.0001
144 BURSITIS 1 0.0001
145 FIBROMYALGIA 2 0.0001
146 MUSCLE SPASTICITY 1 0.0001
147 SPINAL OPERATION 1 0.0001
148 ANHEDONIA 2 0.0001
149 TOOTH INFECTION 1 0.0001
150 EAR INFECTION 2 0.0001
151 QUALITY OF LIFE DECREASED 1 0.0001
152 LIMB INJURY 2 0.0001
153 IMPAIRED GASTRIC EMPTYING 1 0.0001
154 APPLICATION SITE RASH 1 0.0001
155 HUNGER 1 0.0001
156 MASS 1 0.0001
157 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
158 IMPAIRED QUALITY OF LIFE 1 0.0001
159 HYPOKINESIA 1 0.0001
160 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
161 SURGERY 4 0.0001
162 PULMONARY MASS 1 0.0001
163 EJECTION FRACTION DECREASED 1 0.0001
164 ACUTE MYELOID LEUKAEMIA 1 0.0001
165 THERAPY PARTIAL RESPONDER 1 0.0001
166 BASAL CELL CARCINOMA 1 0.0001
167 PRODUCT USE COMPLAINT 1 0.0001
168 OBESITY 1 0.0001
169 SENSORY DISTURBANCE 1 0.0001
170 BLOOD POTASSIUM INCREASED 1 0.0001
171 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
172 GALLBLADDER DISORDER 1 0.0001
173 THIRST 1 0.0001
174 RASH PRURITIC 3 0.0001
175 HYPERHIDROSIS 7 0.0001
176 MIDDLE INSOMNIA 1 0.0001
177 HEPATIC CIRRHOSIS 1 0.0001
178 FOOT FRACTURE 1 0.0001
179 GASTRIC ULCER 1 0.0001
180 SLEEP APNOEA SYNDROME 1 0.0001
181 MIGRAINE 5 0.0001
182 SINUS DISORDER 1 0.0001
183 UPPER LIMB FRACTURE 1 0.0001
184 SPINAL FRACTURE 1 0.0000
185 FULL BLOOD COUNT DECREASED 1 0.0000
186 PRODUCT ADMINISTRATION ERROR 1 0.0000
187 PRODUCT PREPARATION ERROR 1 0.0000
188 TREATMENT FAILURE 4 0.0000
189 DERMATITIS 1 0.0000
190 IRRITABLE BOWEL SYNDROME 1 0.0000
191 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
192 SKIN IRRITATION 2 0.0000
193 NEPHROLITHIASIS 2 0.0000
194 MUSCLE TWITCHING 1 0.0000
195 SLEEP DISORDER 3 0.0000
196 BLOOD PRESSURE FLUCTUATION 1 0.0000
197 NEURALGIA 1 0.0000
198 INJECTION SITE URTICARIA 1 0.0000
199 EPISTAXIS 3 0.0000
200 PNEUMONIA ASPIRATION 1 0.0000
201 CELLULITIS 2 0.0000
202 HAEMATEMESIS 1 0.0000
203 SKIN ULCER 1 0.0000
204 ECZEMA 2 0.0000
205 MUCOSAL INFLAMMATION 1 0.0000
206 JOINT STIFFNESS 1 0.0000
207 PAIN OF SKIN 1 0.0000
208 OEDEMA 2 0.0000
209 SKIN LESION 1 0.0000
210 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
211 ABNORMAL DREAMS 1 0.0000
212 NECK PAIN 2 0.0000
213 NEEDLE ISSUE 1 0.0000
214 LABORATORY TEST ABNORMAL 1 0.0000
215 EMOTIONAL DISTRESS 4 0.0000
216 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
217 INJECTION SITE RASH 1 0.0000
218 FEMUR FRACTURE 1 0.0000
219 BONE DENSITY DECREASED 1 0.0000
220 HEAD INJURY 1 0.0000
221 PULMONARY EMBOLISM 3 0.0000
222 NIGHT SWEATS 1 0.0000
223 PRODUCT DOSE OMISSION ISSUE 9 0.0000
224 CHOLELITHIASIS 1 0.0000
225 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
226 URINARY RETENTION 1 0.0000
227 GAIT INABILITY 1 0.0000
228 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
229 ANGER 1 0.0000
230 NIGHTMARE 1 0.0000
231 RASH 12 0.0000
232 ACCIDENTAL OVERDOSE 1 0.0000
233 RESTLESSNESS 1 0.0000
234 DYSURIA 1 0.0000
235 SEPSIS 3 0.0000
236 EYE SWELLING 1 0.0000
237 COLITIS 1 0.0000
238 ACNE 2 0.0000
239 INJECTION SITE SWELLING 2 0.0000
240 SEIZURE 3 0.0000
241 INJECTION SITE BRUISING 2 0.0000
242 JOINT SWELLING 3 0.0000
243 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
244 EXTRA DOSE ADMINISTERED 1 0.0000
245 ANXIETY 7 0.0000
246 LUNG NEOPLASM MALIGNANT 1 0.0000
247 OSTEOPOROSIS 1 0.0000
248 INJECTION SITE ERYTHEMA 3 0.0000
249 WITHDRAWAL SYNDROME 1 0.0000
250 OSTEOARTHRITIS 1 0.0000
251 DEVICE DISLOCATION 1 0.0000
252 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
253 LIVER DISORDER 1 0.0000
254 COLITIS ULCERATIVE 1 0.0000
255 TINNITUS 1 0.0000
256 SKIN DISCOLOURATION 1 0.0000
257 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
258 HYPERSENSITIVITY 4 0.0000
259 BLOOD CHOLESTEROL INCREASED 1 0.0000
260 COGNITIVE DISORDER 1 0.0000
261 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
262 PRODUCTIVE COUGH 1 0.0000
263 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
264 CONTUSION 2 0.0000
265 INFECTION 3 0.0000
266 FLUSHING 2 0.0000
267 FLUID RETENTION 1 0.0000
268 CHEST DISCOMFORT 2 0.0000
269 SINUSITIS 2 0.0000
270 ERYTHEMA 4 0.0000
271 ILLNESS 2 0.0000
272 HYPERTENSION 4 0.0000
273 DRUG EFFECT DECREASED 1 0.0000
274 CONSTIPATION 4 0.0000
275 TREATMENT NONCOMPLIANCE 1 0.0000
276 PRURITUS 7 0.0000
277 FALL 6 0.0000
278 ARTHROPATHY 1 0.0000
279 WEIGHT DECREASED 5 0.0000
280 URTICARIA 3 0.0000
281 ABDOMINAL DISCOMFORT 3 0.0000
282 HYPONATRAEMIA 1 0.0000
283 MYALGIA 3 0.0000
284 FLATULENCE 1 0.0000
285 URINARY TRACT INFECTION 3 0.0000
286 DEPRESSION 4 0.0000
287 HERPES ZOSTER 1 0.0000
288 LETHARGY 1 0.0000
289 BACK PAIN 4 0.0000
290 COVID-19 3 0.0000
291 BONE PAIN 1 0.0000
292 CHILLS 2 0.0000
293 NASAL CONGESTION 1 0.0000
294 IRRITABILITY 1 0.0000
295 ILL-DEFINED DISORDER 1 0.0000
296 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
297 EXPOSURE DURING PREGNANCY 1 0.0000
298 HEADACHE 10 0.0000
299 DEVICE EXPULSION 1 0.0000
300 SWELLING FACE 1 0.0000
301 BLOOD CREATININE INCREASED 1 0.0000
302 INFUSION RELATED REACTION 1 0.0000
303 FEBRILE NEUTROPENIA 1 0.0000
304 DRY SKIN 2 0.0000
305 INJECTION SITE PRURITUS 1 0.0000
306 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
307 HEPATIC ENZYME INCREASED 1 0.0000
308 PAIN 9 0.0000
309 MEMORY IMPAIRMENT 2 0.0000
310 COUGH 4 0.0000
311 BURNING SENSATION 1 0.0000
312 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
313 THERAPY INTERRUPTED 1 0.0000
314 MOBILITY DECREASED 1 0.0000
315 UNDERDOSE 1 0.0000
316 PAIN IN EXTREMITY 4 0.0000
317 HYPOAESTHESIA 2 0.0000
318 HOT FLUSH 1 0.0000
319 UNEVALUABLE EVENT 1 0.0000
320 CHRONIC KIDNEY DISEASE 1 0.0000
321 CONDITION AGGRAVATED 4 0.0000
322 INJECTION SITE PAIN 4 0.0000
323 HOSPITALISATION 2 0.0000
324 PERIPHERAL SWELLING 2 0.0000
325 DRUG DOSE OMISSION BY DEVICE 1 0.0000
326 ARTHRITIS 1 0.0000
327 PARAESTHESIA 2 0.0000
328 CARDIAC FAILURE CONGESTIVE 1 0.0000
329 THROMBOSIS 1 0.0000
330 DRY MOUTH 1 0.0000
331 INFLUENZA LIKE ILLNESS 1 0.0000
332 ARTHRALGIA 5 0.0000
333 RENAL IMPAIRMENT 1 0.0000
334 SKIN EXFOLIATION 1 0.0000
335 PYREXIA 4 0.0000
336 MUSCULOSKELETAL STIFFNESS 1 0.0000
337 DRUG INEFFECTIVE 15 0.0000
338 INSOMNIA 3 0.0000
339 GASTROINTESTINAL DISORDER 1 0.0000
340 ADVERSE DRUG REACTION 1 0.0000
341 NO ADVERSE EVENT 2 0.0000
342 MUSCLE SPASMS 2 0.0000
343 OROPHARYNGEAL PAIN 1 0.0000
344 CARDIAC DISORDER 1 0.0000
345 SWELLING 1 0.0000
346 PRODUCT USE ISSUE 2 0.0000
347 VOMITING 5 0.0000
348 DYSPHAGIA 1 0.0000
349 DRUG INTOLERANCE 1 0.0000
350 FATIGUE 8 0.0000
351 ALOPECIA 2 0.0000
352 NAUSEA 8 0.0000
353 DIZZINESS 5 0.0000
354 SYNCOPE 1 0.0000
355 DIARRHOEA 6 0.0000
356 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
357 OFF LABEL USE 8 0.0000
358 THROMBOCYTOPENIA 1 0.0000
359 WEIGHT INCREASED 2 0.0000
360 MUSCULAR WEAKNESS 1 0.0000
361 DECREASED APPETITE 2 0.0000
362 DISEASE PROGRESSION 1 0.0000
363 FEELING ABNORMAL 2 0.0000
364 OEDEMA PERIPHERAL 1 0.0000
365 PSORIASIS 1 0.0000
366 DEHYDRATION 1 0.0000
367 VISION BLURRED 1 0.0000
368 BLOOD PRESSURE INCREASED 1 0.0000
369 ACUTE KIDNEY INJURY 1 0.0000
370 TREMOR 1 0.0000
371 CEREBROVASCULAR ACCIDENT 1 0.0000
372 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
373 CHEST PAIN 1 0.0000
374 DYSPNOEA 3 0.0000
375 GAIT DISTURBANCE 1 0.0000
376 HYPOTENSION 1 0.0000
377 ABDOMINAL PAIN UPPER 1 0.0000
378 ABDOMINAL PAIN 1 0.0000
379 ASTHENIA 1 0.0000
380 MALAISE 1 0.0000
381 DEATH 1 0.0000